Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Other Accumulated Expenses: 2011-2024

Historic Other Accumulated Expenses for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $4.5 million.

  • Mimedx Group's Other Accumulated Expenses rose 70.47% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 70.47%. This contributed to the annual value of $4.5 million for FY2024, which is 55.74% up from last year.
  • Latest data reveals that Mimedx Group reported Other Accumulated Expenses of $4.5 million as of FY2024, which was up 55.74% from $2.9 million recorded in FY2023.
  • Mimedx Group's 5-year Other Accumulated Expenses high stood at $4.5 million for FY2024, and its period low was $1.5 million during FY2020.
  • For the 3-year period, Mimedx Group's Other Accumulated Expenses averaged around $3.1 million, with its median value being $2.9 million (2023).
  • Data for Mimedx Group's Other Accumulated Expenses shows a peak YoY soared of 57.80% (in 2023) over the last 5 years.
  • Over the past 5 years, Mimedx Group's Other Accumulated Expenses (Yearly) stood at $1.5 million in 2020, then rose by 6.46% to $1.6 million in 2021, then rose by 17.19% to $1.8 million in 2022, then surged by 57.80% to $2.9 million in 2023, then skyrocketed by 55.74% to $4.5 million in 2024.